Comparing Rock Creek Pharmaceuticals (OTCMKTS:RCPIQ) & FitLife Brands (NASDAQ:FTLF)

Rock Creek Pharmaceuticals (OTCMKTS:RCPIQ) and FitLife Brands (NASDAQ:FTLF) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, analyst recommendations, institutional ownership and dividends.

Analyst Ratings

This is a summary of current recommendations for Rock Creek Pharmaceuticals and FitLife Brands, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rock Creek Pharmaceuticals	0	0	0	0	0.00
FitLife Brands	0	0	1	1	3.50

FitLife Brands has a consensus price target of $40.00, suggesting a potential upside of 20.92%. Given FitLife Brands’ stronger consensus rating and higher possible upside, analysts clearly believe FitLife Brands is more favorable than Rock Creek Pharmaceuticals.

Valuation & Earnings

This table compares Rock Creek Pharmaceuticals and FitLife Brands”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rock Creek Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
FitLife Brands	$60.68 million	2.51	$5.30 million	$1.61	20.55

FitLife Brands has higher revenue and earnings than Rock Creek Pharmaceuticals.

Profitability

This table compares Rock Creek Pharmaceuticals and FitLife Brands’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Rock Creek Pharmaceuticals	N/A	N/A	N/A
FitLife Brands	13.12%	28.06%	15.02%

Insider & Institutional Ownership

2.3% of FitLife Brands shares are owned by institutional investors. 0.9% of Rock Creek Pharmaceuticals shares are owned by company insiders. Comparatively, 61.3% of FitLife Brands shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

FitLife Brands beats Rock Creek Pharmaceuticals on 10 of the 10 factors compared between the two stocks.

About Rock Creek Pharmaceuticals

Rock Creek Pharmaceuticals, Inc. is an early stage life science company, which engages in the discovery, development, and commercialization of new drugs, formulations, and compounds that provide therapies for chronic and acute inflammatory diseases. It focuses on small molecule therapeutics that exhibit anti-inflammatory pharmacological characteristics. The company was founded by Jonnie R. Williams, Sr. on June 24, 1985 and is headquartered in Sarasota, FL.

About FitLife Brands

FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; sports nutrition products; weight loss and sports nutrition products; sports nutrition and general wellness formulations with an emphasis on natural, vegan, and organic ingredients; and male health and weight loss products, as well as other diet, health, and sports nutrition supplements and related products; and value-oriented sports nutrition and weight loss products. It offers MRC products which includes general health supplements; and natural skincare and beauty products. In addition, it markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All-Natural Advice, and Maritime Naturals through franchised stores, as well as through retail locations, which include specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.